Alerts will be sent to your verified email
Verify Email
BIOFILCHEM
|
Biofil Chem & Pharma
|
Makers Laboratories
|
Bharat Immunological
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.42 % | 0.31 % | -29.83 % |
|
5yr Avg Net Profit Margin
|
2.86 % | -0.21 % | -18.38 % |
|
Price to Book
|
3.73 | 1.22 | 1.18 |
|
P/E
|
25.0 | 9.69 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
65.55 Days | 75.08 Days | 206.63 Days |
|
5yr Average Interest Coverage Ratio
|
21.93 | 4.73 | -2.32 |
|
5yr Avg ROCE
|
7.69 % | 6.35 % | -44.64 % |
|
5yr Avg Operating Profit Margin
|
4.5 % | 7.59 % | -18.7 % |
|
5 yr average Debt to Equity
|
0.04 | 0.21 | 0.71 |
|
5yr CAGR Net Profit
|
-10.11 % | n/a | 23.51 % |
|
5yr Average Return on Assets
|
2.72 % | 0.25 % | -10.1 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
46.82 % | 61.27 % | 59.25 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Biofil Chem & Pharma
|
Makers Laboratories
|
Bharat Immunological
|
|---|